SCHEMBL6069455

SCHEMBL6069455

CCCCCCc1cccc(CCCCCC)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 1.00
GPR84 Q9NQS5 1/20 0.48
CYP19A1 P11511 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29058172 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL29869667 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL31246249 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL6466826 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL28879054 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL10790586 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL24973117 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
SCHEMBL6463178 1.00 KCNH2 (1.00) KCNH2GPR84CYP19A1
Hydrochloric Acid SCHEMBL26123438 0.98 KCNH2 (0.96) KCNH2GPR84CYP19A1
SCHEMBL248521 0.98 KCNH2 (0.95) KCNH2GPR84CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026478-B2 Iron catalyzed cross coupling reactions of aromatic compounds STUDIENGESELLSCHAFT KOHLE MBH (DE) 2006-04-11 US disclosed
US-20050075241-A1 Catalyst systems of the ziegler-natta type and a method for production thereof FOTTINGER KLAUS (DE) 2005-04-07 US disclosed
EP-1058696-B1 DONOR-MODIFIED OLEFIN POLYMERIZATION CATALYSTS GRACE W R & CO (US) 2004-04-14 EP disclosed
US-20030220498-A1 Iron catalyzed cross coupling reactions of aromatic compounds STUDIENGESELLSCHAFT KOHLE MBH (DE) 2003-11-27 US disclosed
EP-1326899-A2 CATALYTIC SYSTEMS OF THE ZIEGLER-NATTA TYPE AND METHOD FOR PRODUCTION THEREOF Basell Polyolefine GmbH (DE) 2003-07-16 EP disclosed
WO-2002032969-A2 CATALYTIC SYSTEMS OF THE ZIEGLER-NATTA TYPE AND METHOD FOR PRODUCTION THEREOF BASELL POLYOLEFINE GMBH (DE) 2002-04-25 WO disclosed
US-6228792-B1 CATALYST INCLUDING CERTAIN ALKYL SUBSTITUTED PYRIDINES AS ELECTRON DONORS TO IMPROVE MELT FLOW RATIO AND ORGANOMAGNESIUM COMPOUND TO IMPROVE CATALYST ACTIVITY W. R. GRACE & CO.-CONN. 2001-05-08 US disclosed
EP-1058696-A1 DONOR-MODIFIED OLEFIN POLYMERIZATION CATALYSTS W.R. Grace & Co.-Conn. (US) 2000-12-13 EP disclosed
WO-1999043722-A1 DONOR-MODIFIED OLEFIN POLYMERIZATION CATALYSTS W.R. GRACE & CO.-CONN. (US) 1999-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220498-A1 Iron catalyzed cross coupling reactions of aromatic compounds ARRB1, RBX1, CYP4X1 KCNH2 1010/4885GPR84 547/4885CYP19A1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.